Leon M. Ptaszek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 10 | 2021 | 5127 | 0.760 |
Why?
|
| Heart Conduction System | 3 | 2017 | 1007 | 0.720 |
Why?
|
| Methacrylates | 1 | 2020 | 109 | 0.690 |
Why?
|
| Tissue Adhesives | 1 | 2020 | 173 | 0.620 |
Why?
|
| Gelatin | 1 | 2020 | 220 | 0.620 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2017 | 506 | 0.600 |
Why?
|
| Electric Countershock | 2 | 2019 | 533 | 0.600 |
Why?
|
| Software Design | 1 | 2017 | 171 | 0.570 |
Why?
|
| Ventricular Premature Complexes | 1 | 2017 | 112 | 0.540 |
Why?
|
| Critical Pathways | 2 | 2019 | 474 | 0.530 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 774 | 0.490 |
Why?
|
| Length of Stay | 3 | 2019 | 6426 | 0.470 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 236 | 0.420 |
Why?
|
| Electrodes, Implanted | 2 | 2014 | 840 | 0.390 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 228 | 0.370 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2017 | 1496 | 0.360 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 648 | 0.350 |
Why?
|
| Action Potentials | 1 | 2017 | 1834 | 0.350 |
Why?
|
| Myocardium | 2 | 2020 | 4725 | 0.330 |
Why?
|
| Patient Admission | 1 | 2016 | 1367 | 0.310 |
Why?
|
| Patient Care Team | 1 | 2019 | 2521 | 0.300 |
Why?
|
| Anticoagulants | 2 | 2021 | 4812 | 0.290 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1263 | 0.270 |
Why?
|
| Regeneration | 2 | 2013 | 1512 | 0.270 |
Why?
|
| Heart Rate | 1 | 2017 | 4195 | 0.260 |
Why?
|
| Myocardial Infarction | 5 | 2023 | 11461 | 0.250 |
Why?
|
| Disease Management | 1 | 2016 | 2508 | 0.250 |
Why?
|
| Hospitalization | 4 | 2022 | 10721 | 0.240 |
Why?
|
| DNA Mismatch Repair | 1 | 2007 | 428 | 0.240 |
Why?
|
| Defibrillators, Implantable | 3 | 2015 | 1490 | 0.230 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 1600 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2007 | 838 | 0.230 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 7879 | 0.230 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 1206 | 0.220 |
Why?
|
| Hemochromatosis | 1 | 2005 | 174 | 0.220 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2023 | 42 | 0.210 |
Why?
|
| Genome | 2 | 2008 | 1740 | 0.210 |
Why?
|
| Atrial Appendage | 2 | 2021 | 283 | 0.200 |
Why?
|
| Image Enhancement | 1 | 2012 | 2884 | 0.200 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2023 | 123 | 0.190 |
Why?
|
| Pacemaker, Artificial | 3 | 2019 | 807 | 0.190 |
Why?
|
| Catheter Ablation | 4 | 2018 | 2751 | 0.190 |
Why?
|
| Pericardial Effusion | 2 | 2021 | 247 | 0.190 |
Why?
|
| Chikungunya virus | 1 | 2021 | 56 | 0.190 |
Why?
|
| Equipment Design | 4 | 2018 | 3511 | 0.180 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 1462 | 0.180 |
Why?
|
| Electrocardiography | 6 | 2019 | 6377 | 0.170 |
Why?
|
| Sus scrofa | 2 | 2018 | 428 | 0.170 |
Why?
|
| Drug Compounding | 1 | 2020 | 246 | 0.160 |
Why?
|
| Prosthesis Implantation | 2 | 2021 | 592 | 0.160 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 51 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1964 | 0.160 |
Why?
|
| Heart | 1 | 2012 | 4404 | 0.160 |
Why?
|
| Endocarditis, Bacterial | 1 | 2022 | 436 | 0.150 |
Why?
|
| Endocarditis | 1 | 2022 | 348 | 0.150 |
Why?
|
| Hydrogels | 2 | 2020 | 720 | 0.140 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 292 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 102 | 0.140 |
Why?
|
| Heart Ventricles | 3 | 2018 | 3807 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2022 | 487 | 0.140 |
Why?
|
| Troponin T | 1 | 2021 | 780 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 295 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2009 | 3233 | 0.130 |
Why?
|
| Lyme Disease | 1 | 2021 | 631 | 0.130 |
Why?
|
| Rest | 2 | 2017 | 918 | 0.120 |
Why?
|
| Pyridazines | 1 | 2017 | 202 | 0.120 |
Why?
|
| Tissue Engineering | 2 | 2018 | 1868 | 0.120 |
Why?
|
| Swine | 5 | 2018 | 5915 | 0.120 |
Why?
|
| Coronary Circulation | 2 | 2017 | 1569 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 1166 | 0.120 |
Why?
|
| Ventricular Fibrillation | 2 | 2023 | 537 | 0.110 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 847 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 219 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 2015 | 276 | 0.110 |
Why?
|
| Homeodomain Proteins | 5 | 2011 | 2418 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1241 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2021 | 12794 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 767 | 0.110 |
Why?
|
| Fibrosis | 1 | 2020 | 2049 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2014 | 206 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 2 | 2015 | 2001 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 313 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.100 |
Why?
|
| Temperature | 1 | 2018 | 2226 | 0.100 |
Why?
|
| Animals | 19 | 2020 | 168475 | 0.100 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 575 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 934 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1483 | 0.090 |
Why?
|
| VDJ Recombinases | 4 | 2003 | 84 | 0.090 |
Why?
|
| Cicatrix | 1 | 2017 | 798 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18255 | 0.090 |
Why?
|
| Heart Failure | 3 | 2015 | 11671 | 0.090 |
Why?
|
| Lipids | 1 | 2021 | 3341 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1198 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 20099 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.080 |
Why?
|
| Humans | 38 | 2023 | 761578 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2022 | 80646 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1519 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 2 | 2009 | 1304 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1860 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2775 | 0.080 |
Why?
|
| Cardiology | 1 | 2019 | 1656 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 393 | 0.080 |
Why?
|
| Stroke | 2 | 2021 | 9758 | 0.070 |
Why?
|
| Middle Aged | 15 | 2021 | 220917 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 799 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20569 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 3 | 2002 | 175 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 590 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1642 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3879 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 3627 | 0.070 |
Why?
|
| Pericardium | 1 | 2011 | 675 | 0.070 |
Why?
|
| Esophageal Fistula | 1 | 2007 | 60 | 0.070 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2115 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2021 | 15633 | 0.070 |
Why?
|
| Angina Pectoris | 1 | 2011 | 959 | 0.070 |
Why?
|
| Blastocyst | 1 | 2010 | 433 | 0.070 |
Why?
|
| Male | 20 | 2021 | 360841 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3443 | 0.070 |
Why?
|
| Aged | 11 | 2021 | 169308 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58983 | 0.070 |
Why?
|
| Biomedical Technology | 1 | 2008 | 211 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3096 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2020 | 3407 | 0.060 |
Why?
|
| Immunity | 1 | 2011 | 996 | 0.060 |
Why?
|
| Esophagus | 1 | 2011 | 1033 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 54423 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 997 | 0.060 |
Why?
|
| Pulmonary Veins | 2 | 2010 | 743 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2001 | 1125 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15266 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2010 | 851 | 0.060 |
Why?
|
| Time Factors | 5 | 2021 | 39970 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2010 | 721 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22173 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 794 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9177 | 0.060 |
Why?
|
| Fibroma | 1 | 2006 | 190 | 0.060 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 189 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2557 | 0.060 |
Why?
|
| Models, Molecular | 1 | 1994 | 5439 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 6485 | 0.060 |
Why?
|
| DNA | 6 | 2010 | 7213 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 134 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1345 | 0.060 |
Why?
|
| Adult | 10 | 2021 | 221200 | 0.060 |
Why?
|
| CpG Islands | 1 | 2008 | 1230 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2021 | 1204 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36426 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1668 | 0.050 |
Why?
|
| Female | 15 | 2021 | 392688 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 18398 | 0.050 |
Why?
|
| Liver Failure | 1 | 2005 | 250 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 362 | 0.050 |
Why?
|
| Recurrence | 1 | 2015 | 8466 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 537 | 0.050 |
Why?
|
| Massachusetts | 1 | 2015 | 8830 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5247 | 0.050 |
Why?
|
| California | 1 | 2005 | 1430 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1745 | 0.050 |
Why?
|
| Electronics | 1 | 2022 | 318 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 1555 | 0.050 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2021 | 122 | 0.040 |
Why?
|
| Stem Cells | 1 | 2013 | 3524 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14665 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2805 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1835 | 0.040 |
Why?
|
| Cardiac Tamponade | 1 | 2021 | 175 | 0.040 |
Why?
|
| Burns | 1 | 2011 | 1882 | 0.040 |
Why?
|
| Device Approval | 1 | 2021 | 163 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2006 | 946 | 0.040 |
Why?
|
| Sotalol | 1 | 2019 | 47 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4471 | 0.040 |
Why?
|
| Steam | 1 | 2018 | 33 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 177 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2021 | 578 | 0.040 |
Why?
|
| Ink | 1 | 2018 | 47 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2013 | 10090 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7593 | 0.040 |
Why?
|
| Drug Implants | 1 | 2018 | 230 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 2986 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2014 | 23996 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.040 |
Why?
|
| Placebos | 1 | 2021 | 1667 | 0.040 |
Why?
|
| Risk Factors | 5 | 2015 | 74212 | 0.040 |
Why?
|
| Binding Sites | 4 | 2002 | 6056 | 0.040 |
Why?
|
| Chromatin | 1 | 2008 | 2961 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2000 | 547 | 0.030 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 9610 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2006 | 1955 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2009 | 2781 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 12149 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 699 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2017 | 64684 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9420 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 790 | 0.030 |
Why?
|
| Genome, Human | 1 | 2008 | 4425 | 0.030 |
Why?
|
| Hemothorax | 1 | 2015 | 57 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2018 | 178 | 0.030 |
Why?
|
| Hypotension | 1 | 2021 | 879 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3801 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 863 | 0.030 |
Why?
|
| Incidence | 3 | 2021 | 21355 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10451 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1994 | 154 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1994 | 507 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1271 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1973 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 249 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1492 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18966 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 683 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1994 | 595 | 0.030 |
Why?
|
| Mice | 9 | 2020 | 81539 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 29629 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2112 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12973 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2548 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 714 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2005 | 5496 | 0.020 |
Why?
|
| Kinetics | 2 | 2013 | 6374 | 0.020 |
Why?
|
| Transposases | 2 | 2002 | 104 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2015 | 5293 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1651 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 546 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9326 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1958 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2901 | 0.020 |
Why?
|
| Protein Conformation | 3 | 2002 | 3968 | 0.020 |
Why?
|
| Base Sequence | 3 | 2010 | 12441 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39107 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2011 | 396 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 522 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2244 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2010 | 1058 | 0.020 |
Why?
|
| Dimerization | 2 | 2001 | 891 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3792 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2008 | 110 | 0.020 |
Why?
|
| Chest Pain | 1 | 2015 | 1091 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2008 | 171 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 1045 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2720 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4174 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 959 | 0.020 |
Why?
|
| Dyspnea | 1 | 2015 | 1347 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 17635 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2002 | 1791 | 0.020 |
Why?
|
| Thrombosis | 1 | 2021 | 2942 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 6534 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2897 | 0.020 |
Why?
|
| Syncope | 1 | 2009 | 427 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 755 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 4028 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5205 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 855 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 1084 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2414 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7967 | 0.020 |
Why?
|
| Logistic Models | 2 | 2011 | 13255 | 0.020 |
Why?
|
| Models, Biological | 2 | 2013 | 9469 | 0.010 |
Why?
|
| Point Mutation | 1 | 2010 | 1595 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3415 | 0.010 |
Why?
|
| Adipocytes | 1 | 2011 | 1194 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2707 | 0.010 |
Why?
|
| Computational Biology | 2 | 2008 | 3517 | 0.010 |
Why?
|
| Cattle | 1 | 2010 | 3849 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
| Triage | 1 | 2011 | 986 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11530 | 0.010 |
Why?
|
| DNA, Intergenic | 1 | 2003 | 105 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5774 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.010 |
Why?
|
| Cell Line | 3 | 2003 | 15601 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 279 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2002 | 344 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4125 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3492 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9646 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6075 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 4761 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12725 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2002 | 779 | 0.010 |
Why?
|
| Trypsin | 1 | 2001 | 495 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3549 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2003 | 582 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 92 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4807 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 59254 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4615 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
| Titrimetry | 1 | 1999 | 35 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 1232 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2009 | 1514 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2002 | 4217 | 0.010 |
Why?
|
| Mutation | 2 | 2000 | 30054 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2269 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 13446 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4948 | 0.010 |
Why?
|
| Histones | 1 | 2008 | 2580 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2118 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1141 | 0.010 |
Why?
|
| Catalysis | 1 | 1999 | 774 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 705 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9491 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12059 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5790 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1163 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12341 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 2612 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1739 | 0.010 |
Why?
|
| Zinc | 1 | 1999 | 690 | 0.010 |
Why?
|
| United States | 2 | 2014 | 72335 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3442 | 0.010 |
Why?
|
| Registries | 1 | 2009 | 8224 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2910 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9353 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3733 | 0.010 |
Why?
|
| Software | 1 | 2003 | 4434 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 5079 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41493 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10194 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5799 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 14032 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36193 | 0.000 |
Why?
|